Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: SzingapúrFázis nélkül

Home Play-based Intervention for Parents and Infants

A legfontosabb adatok

Hol
Singapore (Szingapúr)A helyszín megnézése

Helyszínek itt: Szingapúr

  • NTU EMPOWER CentreSingapore, SzingapúrContact: Victoria LeongRésztvevőt keres

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

A vizsgálat adatai

Ki végzi
Nanyang Technological University
Azonosító
NCT07716072
A regiszteradat frissítve
2026. november 12.
Eredeti leírás
The goal of this clinical trial is to learn whether a 12-week home-based intervention (Sociometric Play-based Remediation of Individual Neurodevelopmental Trajectories (SPRINT)) helps support parenting and the development of infants aged 7 - 15 months (at the time they join the study) who were born preterm and/or have a higher family risk of developmental conditions, such as autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and/or global developmental delay (GDD). The main questions it aims to answer are:A teljes eredeti leírásKevesebb

Sociometric Play-based Remediation of Individual Neurodevelopmental Trajectories (SPRINT)

The goal of this clinical trial is to learn whether a 12-week home-based intervention (Sociometric Play-based Remediation of Individual Neurodevelopmental Trajectories (SPRINT)) helps support parenting and the development of infants aged 7 - 15 months (at the time they join the study) who were born preterm and/or have a higher family risk of developmental conditions, such as autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and/or global developmental delay (GDD). The main questions it aims to answer are:

* Does taking part in the SPRINT intervention help parents develop parenting skills? * Does taking part in the SPRINT intervention improve infant's thinking skills and/or socio-emotional development?

Researchers will compare families who receive the SPRINT intervention with families in a waitlist control group to see whether the intervention leads to greater improvements in parents and their children.

Participants will:

* Complete questionnaires and in-person assessments, before and after the 12-week period. * Be assigned to either the SPRINT intervention or a waitlist control group and complete the assigned activities for 12 weeks. * Use the SPRINT app, which provides information, guidance and activities for either the SPRINT intervention or waitlist control group.

Bevonási feltételek: All participants must satisfy the following criteria:; Parent(s) must have access to the internet via a computer, laptop or phone; Parent (s) with adequate English comprehension skills to participate in the study tasks and provide consent; Participants will be included if they meet either of the following criteria at the point of enrolment:; Parent(s) with infants who are identified as having increased familial risk of ASD, ADHD, GDD, related neurodevelopmental disorders or premature birth outcomes. Prematurity is defined as being born before 37 weeks.

Kizáró feltételek: Infants with an identified genetic, metabolic, syndromic, or progressive neurological disorder (e.g., epilepsy, Down or Rett Syndrome, Tuberous Sclerosis, Neurofibromatosis, Fragile X Syndrome), including vascular risk factors; Parent (s) with current or pre-existing diagnosed psychological conditions that may significantly affect their ability to participate in the study, as determined by their referring clinician(s); Participants will be excluded if they meet the following criteria:; Parent(s) and infants with brain injury, severe motor or sensory impairments (e.g., visual or hearing) that would render them unable to participate in the tasks; Parent(s) diagnosed to have impaired intellectual functioning or mental capacity.

ClinicalTrials.gov NCT07716072